| Typicality: | 0.560 |
| Saliency: | 0.727 |
| in the treatment of diabetic nephropathy | 5 | purpose |
| lipid → lower → drug | 47 |
| lipid → lower → anti | 4 |
| negative | neutral | positive |
| 0.174 | 0.636 | 0.190 |
| Raw frequency | 51 |
| Normalized frequency | 0.727 |
| Modifier score | 0.500 |
| Perplexity | 83.310 |